High flow nasal cannula oxygenation in COVID-19 related acute respiratory distress syndrome: a safe way to avoid endotracheal intubation?

BACKGROUNDS: High flow nasal cannula (HFNC) is an alternative therapy for acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19). This study aimed first to describe outcomes of patients suffering from COVID-19-related ARDS treated with HFNC; secondly to evaluate safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Delbove, Agathe, Foubert, Ambroise, Mateos, François, Guy, Tiphaine, Gousseff, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170326/
https://www.ncbi.nlm.nih.gov/pubmed/34057844
http://dx.doi.org/10.1177/17534666211019555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170326/
https://www.ncbi.nlm.nih.gov/pubmed/34057844
http://dx.doi.org/10.1177/17534666211019555

Ejemplares similares